Skip to the reading
The care notebookPeptide care · Choices & questions

Pause and check

Pause when the offer skips an important answer

Set the advert beside the proposed care plan. If a claim cannot be explained, keep it on the question list before committing.

An approval claim needs the right record

Compounding means preparing a medicine from ingredients instead of supplying the factory-made finished product.

FDA means the US medicines agency.

Those compounded medicines have no FDA approval, under the guidance checked on September 26, 2026.

A facility being registered means it is listed with FDA; its products do not gain approval through that listing, as checked on September 26, 2026.

  • Ask which exact product the claim concerns.
  • Ask whether “registered” has been confused with “approved”.
  • Request the record behind either word.

A research label is no reassurance for a patient

FDA had warned companies selling products labelled for research while also giving people instructions for using them, as checked in September 2026.

FDA warned that the quality of those products was unknown and that they could harm people.

  • Ask whether the item in the offer is labelled for research.
  • Request the name of whoever makes and dispenses the product.
  • Check the named pharmacy through the state record.

Keep the medical decision open

The medical boards’ May 2026 guidance rejects treatment selected only from a patient-driven menu.

  • Ask how the assessment could change the proposed plan.
  • Ask whether you can discuss alternatives without committing to a package.
  • Request time to read the reasoning and the quote together.

Sources for this page

Sources checked through September 26, 2026.